Human Biomarkers of Outcome Following Rift Valley Fever Virus Infection

被引：10

作者：

McElroy, Anita K. ^{[1
,2
,3
,4
]}

Harmon, Jessica R. ^{[1
]}

Flietstra, Timothy ^{[1
]}

Nichol, Stuart T. ^{[1
]}

Spiropoulou, Christina F. ^{[1
]}

机构：

[1] US Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Atlanta, GA USA

[2] Emory Univ, Sch Med, Div Pediat Infect Dis, Atlanta, GA 30322 USA

[3] Childrens Healthcare Atlanta, Atlanta, GA USA

[4] Univ Pittsburgh, Sch Med, Div Pediat Infect Dis, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15260 USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2018年 / 218卷 / 11期

基金：

美国国家卫生研究院;

关键词：

Rift Valley fever virus; biomarker; chemokine; inflammation; pathogenesis; CYTOKINE;

D O I：

10.1093/infdis/jiy393

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Rift Valley fever virus is an arbovirus found in Africa and the Middle East. Most infected individuals experience a mild self-limiting illness; however, some develop severe disease including hepatitis, hemorrhagic fever, or encephalitis. The biological reasons for these marked differences in disease manifestation are unknown. In this study, we evaluate 32 biomarkers in serum of 26 patients from an outbreak that occurred in Saudi Arabia in 2000-2001. Eleven biomarkers correlated with viral RNA. Thirteen biomarkers were associated with a fatal outcome. No associations of biomarkers and hemorrhage or central nervous system disease were identified in this cohort.

引用

页码：1847 / 1851

页数：5

共 50 条

[21] HUMAN INFECTION WITH RIFT VALLEY FEVER VIRUS AND IMMUNITY 12 YEARS AFTER SINGLE ATTACK
SABIN, AB
BLUMBERG, RW
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1947, 64 (04): : 385 - 389
[22] Susceptibility and barriers to infection of Colorado mosquitoes with Rift Valley fever virus
Hartman, Daniel A.
Bergren, Nicholas A.
Kondash, Therese
Schlatmann, William
Webb, Colleen T.
Kading, Rebekah C.
PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (10):
[23] Immune correlates of protection following Rift Valley fever virus vaccination
Doyle, Joshua D.
Barbeau, Dominique J.
Cartwright, Haley N.
McElroy, Anita K.
NPJ VACCINES, 2022, 7 (01)
[24] RIFT-VALLEY FEVER VIRUS-INFECTION IN MAN IN NIGERIA
TOMORI, O
JOURNAL OF MEDICAL VIROLOGY, 1980, 5 (04) : 343 - 350
[25] Immune correlates of protection following Rift Valley fever virus vaccination
Joshua D. Doyle
Dominique J. Barbeau
Haley N. Cartwright
Anita K. McElroy
npj Vaccines, 7
[26] Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret
Barbeau, Dominique J.
Albe, Joseph R.
Nambulli, Sham
Tilston-Lunel, Natasha L.
Hartman, Amy L.
Lakdawala, Seema S.
Klein, Ed
Duprex, W. Paul
McElroy, Anita K.
MSPHERE, 2020, 5 (05)
[27] Rift Valley fever virus infection among French troops in Chad
Durand, JP
Bouloy, M
Richecoeur, L
Peyrefitte, CN
Tolou, H
EMERGING INFECTIOUS DISEASES, 2003, 9 (06) : 751 - 752
[28] Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection
de la Fuente, Cynthia
Pinkham, Chelsea
Dabbagh, Deemah
Beitzel, Brett
Garrison, Aura
Palacios, Gustavo
Hodge, Kimberley Alex
Petricoin, Emanuel F.
Schmaljohn, Connie
Campbell, Catherine E.
Narayanan, Aarthi
Kehn-Hall, Kylene
PLOS ONE, 2018, 13 (02):
[29] Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis
Wonderlich, Elizabeth R.
Caroline, Amy L.
McMillen, Cynthia M.
Walters, Aaron W.
Reed, Douglas S.
Barratt-Boyes, Simon M.
Hartman, Amy L.
JOURNAL OF VIROLOGY, 2018, 92 (03)
[30] Curcumin Inhibits Rift Valley Fever Virus Replication in Human Cells
Narayanan, Aarthi
Kehn-Hall, Kylene
Senina, Svetlana
Lundberg, Lindsay
Van Duyne, Rachel
Guendel, Irene
Das, Ravi
Baer, Alan
Bethel, Laura
Turell, Michael
Hartman, Amy Lynn
Das, Bhaskar
Bailey, Charles
Kashanchi, Fatah
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (40) : 33198 - 33214

← 1 2 3 4 5 →